Ryan Brown, MD, Cardiology, Walnut Creek, CA, San Ramon Regional Medical Center


Cardiology Walnut Creek, CA

Adult Congenital Heart Disease, Interventional Cardiology, Nuclear Cardiology, Peripheral Endovascular Interventional Cardiology

Cardiovascular Consultants Medical Group, INC, Associate

Dr. Brown is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brown's full profile

Already have an account?

Education & Training

  • Scripps Clinic
    Scripps ClinicFELLOWSHIP
  • UC Davis Medical Center
    UC Davis Medical CenterFELLOWSHIP
  • University of California Davis
    University of California DavisRESIDENCY
  • University of California Davis
    University of California DavisINTERNSHIP
  • Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2005 - 2006
  • CA State Medical License
    CA State Medical License 2003 - 2021
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology
  • Certification Board of Nuclear CardiologyNuclear Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
  • Member Phi Beta Kappa, 2007
  • B.S. Biology, Cum Laude University of California San Diego, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Sex-Specific Outcomes Following Revascularization with Zotarolimus-eluting Stents: Comparison of angiographic and late-term angiographic outcomes.  
    Brown R, Kandzari, Leon M, Catheterization and Cardiovascular Interventions
  • Clinical Outcomes Following Predilation with a Novel 1.25 mm Diameter Angioplasty Catheter.  
    Kandzari D, Zankar, …. Brown R, Popma J., Catheterization and Cardiovascular Interventions
  • Over the speed limit  
    Robinson,MR Brown, RA, Am J Medicine
  • Join now to see all


  • Nocardial Epidural Abscess in a non-immunocompromised hospital.
    R. Brown, poster, American College of Physicians
  • The Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement Study (BAV-SAVR)
    Babaliaros V,.... R Brown, TCT, Washington, DC
  • Gender-Based Outcomes Following Treatment with Zotarolimus-Eluting stents: Analysis of 6 Clinical Trials
    Kandzari D, .. Brown, RA, ACC


  • Letter to the Editor. Quality of life with PCI versus medical therapy in stable coronary disease 
    Brown RA, Teirstein PS, Kandzari DE., New England Journal of Medicine

Research History

  • Sub-InvestigatorPARTNER: Placement of Aortic Transcatheter Valve Trial2009 - 2010
  • Sub-InvestigatorSEASIDE: Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration with the Endeavor Stent2008 - 2009
  • Sub-InvestigatorHemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients: HOMEOSTASIS II2008 - 2009
  • Sub-InvestigatorA randomized, un-blinded, multicenter Optical Coherence Tomography (OCT) imaging study in patients scheduled for either coronary diagnostic catheterization or intervention. The VOILA Trial.2008 - 2009
  • Sub-InvestigatorAn Unblinded, Multicenter, First-in-Man Imaging Study Comparing the REVO IQ System and Catheter with the Revolution and Atlantis IVUS Imaging Catheters in Subjects Scheduled for Stent Placement. The REVO-IQ Trial2008 - 2009
  • Sub-InvestigatorPREDICT: Scripps Pilot Study on the Effect of High clopidogrel Maintenance Dosing and its Relationship to Cytochrome P450 2C19 Polymorphism Status [STSI/CTSA]2008 - 2009
  • Sub-InvestigatorHuman Recombinant Fibroblast Growth Factor-1 (FGF-1141) for the Treatment of Subjects with Severe Coronary Heart Disease, a Double-blind, Placebo-controlled, Dose-varying study. The FGF Study.2008 - 2009
  • Sub-InvestigatorA 12-month follow up Study to Protocol No. 24779. A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients with Ref2008 - 2009
  • Sub-InvestigatorA Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients with Refractory Chronic Myocardial Ischemia (ACT 34-CMI).2008 - 2009
  • Sub-InvestigatorA Phase II/III, Double-Blind, Randomized, Controlled, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s). The MARVEL Study2008 - 2009
  • Sub-InvestigatorMaintenance of platelet inhibition with cangrelor after discontinuation of thienopyridines in patients undergoing surgery. The BRIDGE Study.2008 - 2009
  • Sub-InvestigatorA Randomized, Double-Blind, Active- Controlled Trial to Evaluate Intravenous and Oral PRT060128, A Selective and Reversible P2Y12-Receptor Inhibitor, vs. Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent Percutaneous Coronary Interventions. The INNOVATE-PCI Study2008 - 2009
  • Sub-InvestigatorA Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to two De Novo Coronary Artery Lesions. The PLATINUM Trial2008 - 2009
  • Sub-InvestigatorA Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25 mm to 4.2 mm. The Medtronic RESOLUTE US Clinical Trial.2008 - 2009
  • Sub-InvestigatorA Prospective Evaluation in a non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS ® Element ™ Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo coronary Artery Lesions in Small Vessels. The PERSEUS Trial: Small Vessel2008 - 2009
  • Sub-InvestigatorA Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System for the Treatment of DeNovo Coronary Artery Lesions. The PERSEUS Trial2008 - 2009
  • Sub-InvestigatorPost-Market Observation Study of Intra-renal Drug Delivery. Short Title: The PROVIDE Study2008 - 2009
  • Sub-InvestigatorGauging Responsiveness with a VerifyNow Assay- Impact on Thrombosis and Safety: GRAVITAS2008 - 2009
  • Sub-InvestigatorIntracoronary Brachytherapy for Recurrent Restenosis after Multiple Drug-Eluting Stents. Short Title: SCRIPPS V2008 - 2009
  • Sub-InvestigatorCarotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the Collection of Clinical Evidence. The CHOICE study2008 - 2009
  • Sub-InvestigatorA Prospective, multi-center randomized controlled trial of the IMPELLA® RECOVER ® LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non-Emergent High Risk PCI. The PROTECT II Trial2008 - 2009
  • Sub-InvestigatorThe effect of cangrelor on the pharmacodynamics of Clopidogrel. A clinical trial comparing cangrelor to Clopidogrel in subjects who require percutaneous coronary intervention. A substudy to Protocol No. TMC-CAN-05-022008 - 2009
  • Sub-InvestigatorA Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention. Protocol No. TMC-CAN-05-02. CHAMPION PCI.2008 - 2009
  • Sub-InvestigatorSCRIPPS DES REAL WORLD REGISTRY: A Prospective Registry for the Use of Cypher™ Sirolimus-Eluting Stent in Patients with Coronary Artery Disease treated with Percutaneous Coronary Interventions at Scripps Clinic2008 - 2009
  • Sub-InvestigatorProspective, Multi-Center, Single-Blind, Two-Arm, Randomized Controlled Trial of the Conor Costar Paclitaxel-Eluting Coronary Stent System Versus the Taxus Drug-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries: Short Title: COSTAR II2008 - 2009
  • Sub-InvestigatorA Multicenter, Randomized Study of the Sirolimus-Eluting Bx Velocity® Balloon- Expandable Stent vs Intravascular Brachytherapy in the Treatment of Patients with In-Stent Restenotic Coronary Artery Lesions. Short Title: The SISR Study2008 - 2009
  • Sub-InvestigatorA Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting Bx VelocityTM Balloon-Expandable Stent in the Treatment of Patients With DeNovo Native Coronary Artery Lesions (Protocol P03-6320) (SIRIUS 2.25mm)2008 - 2009

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations